Physician profile
Christopher S Hall
NPI 1558442293
$4,026.60
in general payments reported to CMS, 2019-2025
31 companies · $1,266 in 2025
The $1,266 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $787 · 2020: $159 · 2021: $32.82 · 2022: $263 · 2023: $678 · 2024: $841 · 2025: $1,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,785.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $605.81 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $563.29 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $376.93 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $368.55 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Dexcom, INC. | $246.46 | 2024-2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Abbott Laboratories | $225.25 | 2023-2025 | Freestyle Libre 3, Eterna |
| Pfizer INC. | $224.11 | 2019-2025 | |
| Exact Sciences Corporation | $214.12 | 2023-2025 | Cologuard Collection Kit |
| Itamar Medical INC | $128.15 | 2022-2025 | Watchpatone |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.61 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $124.75 | 2019-2024 | Spravato |
| Amgen INC. | $117.42 | 2019-2025 | Krystexxa, Repatha, Prolia |
| Idorsia Pharmaceuticals US INC | $94.60 | 2022-2024 | Quviviq |
| Merck Sharp & Dohme LLC | $69.67 | 2019-2024 | Gardasil 9, Capvaxive, Gardasil |
| Abbvie INC. | $67.08 | 2023-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $61.92 | 2019-2020 | |
| Amarin Pharma, INC. | $56.86 | 2019 | |
| Siemens Medical Solutions USA, INC. | $55.77 | 2021-2022 | |
| Dynavax Technologies Corporation | $41.06 | 2023-2025 | Heplisav-B |
| Bayer Healthcare Pharmaceuticals INC. | $35.79 | 2023-2025 | |
| Shire North American Group INC | $26.01 | 2019 | |
| Valeritas, INC. | $24.56 | 2019 | |
| Madrigal Pharmaceuticals | $23.41 | 2025 | Rezdiffra |
| Philips North America LLC | $22.66 | 2024 | (Ck7) Extended Holter |
| Seqirus USA INC | $22.06 | 2024 | Flucelvax, Fluad |
| Inspire Medical Systems, INC. | $19.69 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $19.33 | 2020 | |
| Edwards Lifesciences Corporation | $17.98 | 2024 | Sapien 3 Ultra Resilia |
| Antares Pharma, INC. | $17.68 | 2020 | |
| Astellas Pharma US INC | $15.24 | 2025 | Veozah |
| Acerus Pharmaceuticals Corporation | $14.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.